rss
Br J Ophthalmol 93:132 doi:10.1136/bjo.2008.144238
  • Letter
    • PostScript

Methylation in uveal melanoma

  1. P A van der Velden,
  2. W Maat
  1. Department of Ophthalmology, LUMC, Leiden, The Netherlands
  1. Dr P A van der Velden, LUMC, Einthovenweg 20, 2300RC Leiden, The Netherlands; velden{at}lumc.nl
  • Accepted 28 May 2008
  • Published Online First 23 July 2008

Epigenetic regulation of tumour suppressor genes provides an attractive mechanism for tumours in which mutations and structural changes are rare. The latter may apply to uveal melanoma for which little is known of the genes that contribute to tumour development. In the search for genes, uveal melanoma is often compared with its counterpart in the skin, cutaneous melanoma. One of the major cuteneous melanoma genes is the p16 encoding CDKN2A gene for which mutations and deletions are the major mechanisms of inactivation. Deletions and mutations in CDKN2A are, however, rare in uveal melanoma; still p16 expression is lacking in half of the cell lines.1 Using methylation analysis and methylation inhibition in cell culture, we have shown that the underlying mechanism of loss of p16 expression in these cell lines …

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.